Peter DeLong

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy
    Peter DeLong
    Thoracic Oncology Laboratory, 8th Floor BRB II III, University of Pennsylvania Medical Center, 421 Curie Boulevard, Philadelphia, PA 19104, USA
    Cancer Res 63:7845-52. 2003
  2. ncbi request reprint Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma
    Robert J Kruklitis
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA
    J Thorac Cardiovasc Surg 127:123-30. 2004
  3. ncbi request reprint Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy
    Daniel H Sterman
    Thoracic Oncology Research Laboratory, University of Pennsylvania Medical Center, Philadelphia, PA 19104 4283, USA
    Clin Cancer Res 11:7444-53. 2005
  4. ncbi request reprint Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma
    Peter DeLong
    Thoracic Oncology Research Laboratory, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer Biol Ther 4:342-6. 2005
  5. ncbi request reprint Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy
    Makoto Odaka
    Thoracic Oncology Research Laboratory, University of Pennsylvania Medical Center, Philadelphia, 19104, USA
    Mol Ther 6:210-8. 2002
  6. ncbi request reprint Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling
    Sunil Singhal
    Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer Biol Ther 2:291-8. 2003
  7. ncbi request reprint Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta
    Omar Tliba
    Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 278:50615-23. 2003

Detail Information

Publications7

  1. ncbi request reprint Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy
    Peter DeLong
    Thoracic Oncology Laboratory, 8th Floor BRB II III, University of Pennsylvania Medical Center, 421 Curie Boulevard, Philadelphia, PA 19104, USA
    Cancer Res 63:7845-52. 2003
    ....
  2. ncbi request reprint Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma
    Robert J Kruklitis
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA
    J Thorac Cardiovasc Surg 127:123-30. 2004
    ....
  3. ncbi request reprint Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy
    Daniel H Sterman
    Thoracic Oncology Research Laboratory, University of Pennsylvania Medical Center, Philadelphia, PA 19104 4283, USA
    Clin Cancer Res 11:7444-53. 2005
    ..HSVtk) in combination with systemic ganciclovir...
  4. ncbi request reprint Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma
    Peter DeLong
    Thoracic Oncology Research Laboratory, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer Biol Ther 4:342-6. 2005
    ..These results have implications for the development of immunotherapy directed to the malignant pleural space, and suggest the need to tailor immunotherapy to overcome immunosuppressive mechanisms in tumor environments...
  5. ncbi request reprint Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy
    Makoto Odaka
    Thoracic Oncology Research Laboratory, University of Pennsylvania Medical Center, Philadelphia, 19104, USA
    Mol Ther 6:210-8. 2002
    ..IFN-beta may be different in different tumor types or in different anatomic locations. However, these results demonstrate that tumor-specific CD4(+) and CD8(+) T cells are the key effector cells for tumor eradication in this model...
  6. ncbi request reprint Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling
    Sunil Singhal
    Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer Biol Ther 2:291-8. 2003
    ..e., cdc2, cullin 4A, ZAC, p57, DP-1, GADD45, PISSLRE, cdc20) nor in any other tumors (i.e., cyclin F, cullin 5, p34). These results identified several potential cell cycle genes altered in lung cancer...
  7. ncbi request reprint Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta
    Omar Tliba
    Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 278:50615-23. 2003
    ..Together these data show that TNFalpha, via the autocrine action of IFNbeta, differentially regulates the expression of proinflammatory genes and DNA synthesis...